These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 9493594
1. Effect of antihypertensive treatment with doxazosin on insulin sensitivity and fibrinolytic parameters. Zehetgruber M, Christ G, Gabriel H, Mundigler G, Beckmann R, Binder BR, Huber K. Thromb Haemost; 1998 Feb; 79(2):378-82. PubMed ID: 9493594 [Abstract] [Full Text] [Related]
2. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M. Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914 [Abstract] [Full Text] [Related]
3. Adrenoreceptors, endothelial function, and lipid profile: effects of atenolol, doxazosin, and carvedilol. González Maqueda I. Coron Artery Dis; 1994 Nov; 5(11):909-18. PubMed ID: 7719523 [Abstract] [Full Text] [Related]
4. [Effects of doxazosin and hydralazine on insulin sensitivity and sympathetic function in spontaneously hypertensive rat (SHR)]. Takahashi A, Kushiro T, Kanmatsuse K. Nihon Jinzo Gakkai Shi; 1998 May; 40(4):240-4. PubMed ID: 9654906 [Abstract] [Full Text] [Related]
8. Effect of doxazosin on fibrinolysis in hypertensive patients with and without insulin resistance. Jeng JR, Sheu WH, Jeng CY, Huang SH, Shieh SM. Am Heart J; 1996 Oct; 132(4):783-9. PubMed ID: 8831367 [Abstract] [Full Text] [Related]
9. Doxazosin and hydrochlorothiazide equally affect arterial wall thickness in hypertensive males with hypercholesterolaemia (the DAPHNE study). Doxazosin Atherosclerosis Progression Study in Hypertensives in the Netherlands. Hoogerbrugge N, de Groot E, de Heide LH, de Ridder MA, Birkenhägeri JC, Stijnen T, Jansen H. Neth J Med; 2002 Oct; 60(9):354-61. PubMed ID: 12572707 [Abstract] [Full Text] [Related]
11. Add-on therapy with a nighttime dose of doxazosin in patients with uncontrolled hypertension: effects on autonomic modulation of the cardiovascular system. Guzik P, Wykretowicz A, Krauze T, Piskorski J, Adamska K, Milewska A, Wesseling KH, Wysocki H. Hypertens Res; 2008 Mar; 31(3):443-53. PubMed ID: 18497463 [Abstract] [Full Text] [Related]
12. [Antihypertensive therapy with doxazosin in patients with non-insulin-dependent diabetes mellitus]. Lazebnik LB, Melichenko SB, Serebrov AN. Ter Arkh; 1998 Mar; 70(2):50-4. PubMed ID: 9551574 [Abstract] [Full Text] [Related]
13. Effects of doxazosin on hemorheological, hemodynamic and lipid parameters in patients with essential hypertension. Toth K, Nemes J, Czopf L, Kapronczay P, Kesmarky G, Juricskay I. Clin Hemorheol Microcirc; 1999 Mar; 20(1):57-61. PubMed ID: 11185685 [Abstract] [Full Text] [Related]
14. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug. Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M. Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208 [Abstract] [Full Text] [Related]
20. Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension. Liu L, Zhao SP, Zhou HN, Li QZ, Li JX. J Cardiovasc Pharmacol; 2007 Jul; 50(1):50-5. PubMed ID: 17666915 [Abstract] [Full Text] [Related] Page: [Next] [New Search]